Teva's innovation engine mitigates generics slump
Ajovy faces unexpected surge
Analyst shocked by Ajovy performance
Teva's specialty portfolio outperforms expectations
Generics revenue declines despite pricing pressure
Teva's growth driven by innovative brands and emerging markets
Teva's innovation pipeline shows promising results
Ajovy positions Teva as a leader in migraine treatments
Teva maintains focus on innovation despite generics challenges
Teva's strategic shift toward specialty drugs and innovation
Teva's innovation strategy offsets generics slowdown
Teva's strong performance in key therapeutic areas
Ajovy's surge challenges analyst expectations
Teva's innovation-driven growth model gains traction
Teva's specialty brands drive overall revenue growth
Analysts reassess Teva's valuation based on innovation success
Teva's innovation engine inspires confidence in long-term growth
Teva's strategic pivot toward high-growth specialty markets
Ajovy's success highlights Teva's innovation capabilities
Teva's innovation engine transforms company outlookSources: